GRANTED PATENTS

 
S.No. Title

Patent No.

Country

Granted
on

1. Birth control vaccine 1239346 Canada 19.07.88
2. Birth control vaccine 2087661 Japan 04.06.89
3. Birth control vaccine  4780312 USA 25.10.88
4. Birth control vaccine  86103854.1 China 04.06.84
5. Birth control vaccine  0204566 France 27.05.92
6. Birth control vaccine  2024566 Switzerland 27.05.92
7. Birth control vaccine  0204566 U.K. 27.05.92
8. Birth control vaccine 36854557 Germany 27.05.92
9. Birth control vaccine  0204566 Sweden 27.05.92
         
10. A recombinant birth control vaccine 647040 Australia 17.03.94
11. A recombinant birth control vaccine 614520 Canada 16.02.99
12. A recombinant birth control vaccine 0494158 Switzerland 10.03.99
13. A recombinant birth control vaccine 0494158 U.K. 10.03.99
         
14. Anti-cancer utility of hCG Vaccine 5762931 USA 09.06.98
         
15. Antigenic derivative of GnRH 2228262 U.K. 07.10.92
         
16. Tuberculosis vaccine comprising M. w 2236480 U.K. 08.08.89
         
17. Reversible fertility control for prevention of pregnancy in females 5196197 USA 23.03.93
         
18. Composition containing neem oil for fertility control and prevention of pregnancy 90309454.8 Switzerland 06.12.95
19. Composition containing neem oil for fertility control and prevention of pregnancy 90309454.8 Germany 06.12.95
20. Composition containing neem oil for fertility control and prevention of pregnancy 90309454.8 France 06.12.95
21. Composition containing neem oil for fertility control and prevention of pregnancy 90309454.8 U.K. 06.12.95
         
22. A method for establishing a tumor cell line by preparing a single cell suspension of Tumor cells from tumor biopsies 574436388 USA 28.04.98
         
23. A drug for the treatment of cancer 707158 Australia Allowed
24. A drug for the treatment of cancer   USA Allowed
         
25. A method for enhancing foreign gene expression in Baculovirus expression vector system 5965393 USA 12.10.99
         
26. Application of protoberberine alkaloid, berberine, as an immuno-suppressive agent 5856487 USA 05.01.99
         
27. Process of isolation and synthesis of 1-(3,4-Methylenedioxy-phenyl)-1E- tetra-decene and its analogs and a method for activation of effector mechanisms of the immune system against tumors &/or infections using formulations containing these compounds 5962515 USA 05.10.99
         
28. Method for modifying and increasing an immune response   Australia Allowed


HomeAbout NII  | Research Programme Academic ProgrammeDirectory
Publications
  |  Infrastructure  |   Patents Alumni